Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 11626 - 11650 of 12791 in total
Experimental
Matched Iupac: … [3-(2-iodoacetamido)phenyl]boronic acid …
Experimental
Matched Iupac: … (2S)-5-(carbamoylamino)-2-acetamidopentanoic acid …
Experimental
Matched Iupac: … (2R)-2-amino-3-sulfinylpropanoic acid …
Experimental
Matched Iupac: … (3S,4S)-1,3,4,5-tetrahydroxypentan-2-one …
Experimental
Matched Iupac: … (2S)-2-(carbamoylamino)-3-phenylpropanoic acid …
Palifosfamide (ZIO-201) is a proprietary stabilized metabolite of ifosfamide. Ifosfamide has been shown to be effective in high doses in treating testicular cancer, sarcoma and lymphoma.
Investigational
Matched Iupac: … bis[(2-chloroethyl)amino]phosphinic acid …
Experimental
Matched Iupac: … (2R)-2-(3-sulfanylpropanamido)propanoic acid …
Experimental
Matched Iupac: … (2R)-2-(4-methoxybenzenesulfonamido)propanoic acid …
Flurothyl is a convulsant primarily used in experimental animals. It was formerly used to induce convulsions as a alternative to electroshock therapy.
Withdrawn
Matched Iupac: … 1,1,1-trifluoro-2-(2,2,2-trifluoroethoxy)ethane …
Safingol has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.
Investigational
Matched Iupac: … (2S,3S)-2-aminooctadecane-1,3-diol …
Etilamfetamine is also known as N-ethylamphetamine and is in the Canadian Legislation - The Controlled Drugs and Substances Act, and is a Schedule 1 controlled drug. Like other amphetamines, this amphetamine analog was used as an appetite suppressant in the 1950s. However, being on the controlled drug and substance act...
Experimental
Matched Iupac: … ethyl(1-phenylpropan-2-yl)amine …
Experimental
Matched Iupac: … 1-(1-phenylpentan-2-yl)pyrrolidine …
Adelmidrol is under investigation in clinical trial NCT01420510 (Saginil in vs. Placebo for Gynecologic Oncology Patients Affected by Vaginitis).
Investigational
Matched Iupac: … N,N'-bis(2-hydroxyethyl)nonanediamide …
Osalmid is under investigation in clinical trial NCT03670173 (Safety and Efficacy Assessments of Osalmid in Multiple Myeloma).
Investigational
Matched Iupac: … 2-hydroxy-N-(4-hydroxyphenyl)benzamide …
Investigational
Matched Iupac: … 1,2,3-triethyl 2-hydroxypropane-1,2,3-tricarboxylate …
Investigational
Matched Iupac: … 3-[(2-carboxyethyl)diselanyl]propanoic acid …
Experimental
Matched Iupac: … 3-[(2Z)-2-{[4-(2-carboxyethyl)-5-{[(2Z)-3-ethyl-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]methyl ... }-3-methyl-1H-pyrrol-2-yl]methylidene}-5-{[(2Z)-3-ethyl-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene …
Experimental
Matched Iupac: … (2R,3R)-2-aminobutane-1,3-diol …
Experimental
Matched Iupac: … (2R)-3-(acetylsulfanyl)-2-aminopropanoic acid …
Experimental
Matched Iupac: … (2R)-2-amino-6-hydroxyhexanoic acid …
Experimental
Matched Iupac: … [2-(N-bromoacetamido)ethoxy]phosphonic acid …
Experimental
Matched Iupac: … (2S)-2-acetamido-3-hydroxypropanoic acid …
Experimental
Matched Iupac: … 6-(cyclohexylmethoxy)-9H-purin-2-amine …
Experimental
Matched Iupac: … 2-[(diaminomethyl)(methyl)amino]acetic acid …
Experimental
Matched Iupac: … (2R)-2-amino-3-disulfanylpropanoic acid …
Displaying drugs 11626 - 11650 of 12791 in total